Biallelic pathogenic variants in NARS2 cause COXPD24, a clinically heterogeneous disorder characterized by early-onset epilepsy, global developmental delay, abnormal muscle tone, progressive encephalopathy, sensorineural hearing loss, cardiomyopathy, and elevated lactate levels. Here, NARS2 is linked to epilepsy.